Placebo | 100 U EPO | 500 U EPO | 2,500 U EPO | 5,000 U EPO | 0.3 mg IGF-1 | 3 mg IGF-1 | |
N | 78 | 20 | 16 | 14 | 16 | 14 | 15 |
Cell No. (×109) | 2.98 ± 0.27 | 3.03 ± 0.29 | 2.91 ± 0.26 | 2.76 ± 0.32 | 2.25 ± 0.25 | 2.84 ± 0.42 | 2.5 ± 0.28 |
Delta BW (g) | −53.7 ± 1.8 | −30.6 ± 9.6*** | −39.6 ± 8.9* | −29.1 ± 10.1*** | −47.4 ± 5.9 | −39.6 ± 11.1* | −42.7 ± 8.8* |
Delta lean mass (g) | −39.8 ± 1.6 | −23.7 ± 7.4** | −30.3 ± 6.81* | −21.6 ± 7.7*** | −35.4 ± 4.6 | −28.8 ± 8.4* | −30.6 ± 7.4 |
Delta fat mass (g) | −12.4 ± 0.4 | −8.0 ± 1.7*** | −10.5 ± 1.5 | −8.4 ± 1.5*** | −11.2 ± 0.9 | −12.4 ± 1.9 | −11.0 ± 1.3 |
Food (g/24 h) | 4.3 ± 0.48 | 7.85 ± 1.66** | 6.56 ± 1.73 | 6.57 ± 1.89 | 5.38 ± 1.19 | 2.5 ± 1.66 | 11.8 ± 9.82 |
Activity (counts/24 h) | 29,509 ± 1,775 | 38,550 ± 4,412* | 36,915 ± 3,854 | 38,893 ± 6,012 | 40,342 ± 4,630* | 35,685 ± 4,637 | 29,962 ± 5,139 |